geuvadis_rnaseq March 2013

geuvadis_rnaseq@lists.crg.es

6 participants
4 discussions

Re: [Geuvadis_rnaseq] Geuvadis RNAseq manuscript draft

by Tuuli Lappalainen

Dear all, The revised version of the Geuvadis RNAseq main paper has been resubmitted to Nature. The manuscript files are enclosed for your reference. Time to cross fingers again - let's hope for the best! best regards, Tuuli Tuuli Lappalainen, PhD Department of Genetics, Stanford University School of Medicine , and Department of Genetic Medicine and Development, University of Geneva Email: tuuli.e.lappalainen(a)gmail.com / tlappala(a)stanford.edu Tel: +1 415 351 9713 Bustamante lab Department of Genetics 300 Pasteur Dr. Lane L301 Stanford, CA 94305-5120 USA

11 years, 6 months

[Geuvadis_rnaseq] Conference: GENOMIC MEDICINE IN THE MEDITERRANEAN

by Manolis Dermitzakis

Dear all, Please see the link below for a conference that Nico Katsanis and I are organizing: Genomic Medicine in the Mediterranean (GM^2 ) Crete, Oct 2-5, 2013 *www.gm2conferences.com * Let me know if you have any questions. Registration and abstract submission is open. Cheers Manolis -- ------------------------------------------ Emmanouil (Manolis) Dermitzakis, PhD Louis-Jeantet Professor Department of Genetic Medicine and Development University of Geneva Medical School 1 Rue Michel-Servet (CMU office 9088) Geneva 1211 Switzerland Email: emmanouil.dermitzakis(a)unige.ch Tel: +41 (0) 22 379 5483 Fax: +41 (0) 22 379 5706 website: http://funpopgen.unige.ch/ Admin assistant: Ancilla Stefani, Tel: +41 22 379 5551 e-mail: Ancilla.Stefani(a)unige.ch ------------------------------------------

11 years, 6 months

[Geuvadis_rnaseq] Geuvadis RNA-seq paper revision

by Tuuli Lappalainen

Dear all, We have revised the Geuvadis RNA-seq paper for Nature; please find the paper and the response letter enclosed. If you have any comments, please send them *by Saturday* - apologies for the tight schedule, we are planning to submit this on Monday. Thanks to all of you who helped me with the revisions. As many of you know, the editor adviced us to make the paper more focused on the key messages, and as a consequence we had to drop some of the analyses - fusion transcripts, soft splicing and RNA editing. I hope that those results can be published in some other context later on. To strengthen the analysis of regulatory variants, I did some additional analysis on regulatory variants underlying allele-specific expression signals, but otherwise the changes in the paper are relatively small. I think that we were able to respond to all the comments really well, and hopefully the editor and reviewers agree. best regards, Tuuli -- Tuuli Lappalainen, PhD Department of Genetics, Stanford University School of Medicine , and Department of Genetic Medicine and Development, University of Geneva Email: tuuli.e.lappalainen(a)gmail.com / tlappala(a)stanford.edu Tel: +1 415 351 9713 Bustamante lab Department of Genetics 300 Pasteur Dr. Lane L301 Stanford, CA 94305-5120 USA

11 years, 6 months

[Geuvadis_rnaseq] abstract submission

by P.A.C._t_Hoen＠lumc.nl

Dear all I intend to submit this abstract (or a very similar version) to: -the annual meeting of the Netherlands Bioinformatics Center -ISMB (likely HitSeq SIG) Please let me know if you have any comments Best Peter Dr. Peter A.C. 't Hoen Department of Human Genetics Leiden University Medical Center Room S4-36 Postal zone S4-P PO Box 9600 2300 RC Leiden The Netherlands phone: +31-71-5269421 fax: +31-71-5268285 e-mail: p.a.c.hoen(a)lumc.nl

11 years, 6 months

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

geuvadis_rnaseq March 2013